Cipta Sarana Medika Tbk. vs Ketrosden Triasmitra Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Ketrosden Triasmitra Tbk. trades at Rp570 (market cap 1.56T, 10.53M 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 9.6× Cipta Sarana Medika Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (10.53M versus 3.92M). Which is the better fit depends on your goals.
| DKHH | KETR | |
|---|---|---|
Market Cap | 163.22B | 1.56T |
Volume | 3.92M | 10.53M |
Lot | 39.16K | 105.32K |
Turnover | 249.6M | 5.98B |
Average Price | 63.74 | 567.88 |
Value | 249.6M | 5.98B |
Indicative Equilibrium Price | 64 | 570 |
Indicative Equilibrium Volume | 77 | 8.62K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.
Read more on KETR →